KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查

Immune checkpoint inhibitors for first-line treatment of advanced esophageal squamous cell carcinoma.

Maria Alsina, Tania Fleitas-Kanonnikoff

Med 5(9) 1038-1040

PMID39276766
PMCID-
DOI10.1016/j.medj.2024.05.016
发表日期2024-09-14
摘要

摘要

Immunotherapy has revolutionized the treatment landscape of esophageal squamous cell carcinoma. He et al. present the final results of the randomized phase 3 ESCORT-1st trial, confirming positive survival outcomes when adding the anti-PD1 inhibitor camrelizumab to first-line chemotherapy treatment in Chinese patients with esophageal squamous cell cancer.1.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。